Waters (WAT) Stock Price
Waters Price
Over the last 19 years Waters grew revenue by 4.9% annually, reaching 3.17 B USD. Earnings per share have grown at 8.8% per year over the last 19 years. For Waters, the net margin of 20.3% is down versus 24.9% a few years ago. The consensus 12-month price target for Waters is 420.00 USD, about 1.2% below where the stock trades today. Of 31 analysts, 20 rate the stock a buy — an overall Buy consensus.
Waters stock price
Waters business model & stock analysis
Frequently asked questions about Waters
The business model of Waters Corp is focused on the development, manufacturing, and distribution of analytical instruments and software used in the life sciences, pharmaceutical, and chemical analysis industries. Waters Corp offers a wide range of products and solutions for high-performance liquid chromatography (HPLC), mass spectrometry (MS), and thermal analysis. With a commitment to technological advancements, Waters Corp aims to provide precise and reliable solutions to its customers, enabling them to improve productivity, enhance research outcomes, and ensure regulatory compliance. By leveraging their expertise in analytical science, Waters Corp continues to be a trusted name in the industry, catering to the evolving needs of scientists and researchers worldwide.
Waters Corp is primarily active in the scientific instruments and equipment industry. As a leading provider of innovative analytical solutions, Waters Corp serves a wide range of industries including pharmaceutical, biotechnology, chemical, environmental, food and beverage, and clinical research. With its advanced technology and expertise, the company is dedicated to assisting customers in improving their productivity and making scientific discoveries. Waters Corp’s commitment to excellence and precision has established its strong presence in various sectors, making it a trusted partner for analytical solutions across multiple industries.
The main competitors of Waters Corp in the market include Agilent Technologies, PerkinElmer, Thermo Fisher Scientific, and Shimadzu Corporation.
Waters Corp is a leading company in the analytical instruments industry. Established in 1958, Waters Corp has a rich history of providing innovative solutions for chemical analysis and separations science. The company has been instrumental in developing state-of-the-art technologies that cater to the ever-evolving needs of various industries including pharmaceutical, environmental, and food & beverage. With a strong commitment to research and development, Waters Corp has continuously introduced cutting-edge products and services that drive scientific advancements. Today, Waters Corp stands as a trusted and respected name in the field, serving customers worldwide with its reliable and accurate analytical instruments.
Waters Corp has achieved several significant milestones throughout its history. Established in 1958, the company revolutionized liquid chromatography with the development of the first high-performance liquid chromatography (HPLC) system in 1971. In the following years, Waters Corp continued to innovate and pioneered various advancements in chromatography technology, including the introduction of the Acquity UPLC system in 2004. The company has also expanded globally and established a strong presence in key markets, with offices and facilities in over 50 countries. Additionally, Waters Corp has received recognition and numerous awards for its contributions to analytical science and commitment to customer satisfaction.
Waters Corp, a leading company in the stock market, primarily operates in multiple countries and regions worldwide. With a global presence, the company has established its footprint in key markets such as the United States, Europe, Asia Pacific, and Latin America. Waters Corp's extensive distribution network allows them to serve customers in diverse industries and sectors across these regions. As a result, investors can benefit from the company's broad geographical reach, which provides opportunities for growth and market expansion.
Waters Corp represents values of innovation, reliability, and customer focus. With a strong commitment to providing high-quality analytical science solutions, Waters Corp is dedicated to solving complex challenges in various industries. Their corporate philosophy revolves around empowering scientists and researchers to make groundbreaking discoveries and advancements. By leveraging cutting-edge technology and a deep understanding of customer needs, Waters Corp strives to deliver exceptional products and services. The company's culture promotes collaboration, integrity, and continuous improvement, ensuring that they remain a trusted partner and industry leader in analytical sciences.
Analysts currently set an average price target of 420.64 USD for the Waters stock (median: 420.00 USD), implying -4.4 % versus the latest price. The consensus is based on 31 analyst ratings.
31 analysts currently rate the Waters stock: 20 recommend buying, 11 holding and 0 selling. For 2026, analysts expect Waters to generate revenue of 6.46 B USD and earnings per share of 14.56 USD.
Converted at the current exchange rate, the Waters share trades at 377.96 EUR (425.21 USD).
The Waters share (WAT) is listed on 7 stock exchanges, including: NYSE (WAT), London (0LTI.L), SIX (Zürich) (WAZ.SW), Frankfurt (WAZ.F), München (WAZ.MU), Düsseldorf (WAZ.DU).
The Waters Corporation is an American company specializing in providing analysis equipment and software for various industries, particularly the pharmaceutical and biotechnology industries. The company was founded in 1958 and is headquartered in Milford, Massachusetts. The company's business model includes various divisions such as Life Science, Clinical, Chemical Materials, Environmental, Food, Forensic, Petrochemical, and Pharmaceutical. Each of these areas has specific requirements for analysis, and Waters Corporation offers customized solutions in each division. The company offers a variety of products, including chromatography systems, mass spectrometers, software for data analysis, and metabolite determination. The company has thousands of employees worldwide and operates branches in North America, Europe, Asia, and the Middle East. In the Life Science division, Waters Corporation offers products for the pharmaceutical industry, including a wide range of devices for quality control and drug analysis. For bioanalysis, the company provides instrumental technologies for proteomics analysis, peptide mapping, glycan analysis, and metabolic pathways. The Clinical division focuses on clinical laboratories and offers advanced chromatography and spectrometer systems that enable rapid and accurate diagnosis. Similarly, the Petrochemical division provides a wide range of analysis equipment for the petrochemical industry to test oil and gas products. The Chemical Materials division specializes in the development of materials and offers various analysis systems to monitor the quality and performance of materials. The Environmental division is responsible for the analysis of environmental samples to assess contamination in food and water sources. The Food division specializes in quality control of food and offers analysis equipment to examine the composition, nutrient content, contaminants, and allergens in food. Forensics supports justice authorities in investigating crime scenes and analyzing evidence through instruments for chemical analysis. In summary, Waters Corporation's business is focused on providing customized solutions for specific requirements in various industries. The combination of instruments and software for data analysis allows the company to deliver innovative products and services, ensuring high customer satisfaction.
The expected revenue of Waters is 6.46 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Waters is 870.10 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Waters is currently 29.21. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Waters stock.
The price-to-sales ratio (P/S) of Waters is currently 3.94. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Waters stock.
The Eulerpool Quality Score for Waters is 4/10.
The ISIN of Waters is US9418481035. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Waters is 898123. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Waters is WAT. The ticker symbol is used to trade Waters shares on the stock exchange.
Waters stock
Waters Peer Group
Waters Ticker
Waters FIGI
All fundamentals and in-depth analysis of Waters
Our stock analysis for Waters stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Waters. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.